We develop submissions in response to policy and legislative consultations on a wide range of issues affecting the specialty and the wider health sector.

Key advocacy issues in 2021

  • New Zealand’s Health and Disability System Review, described as “a once in a generation opportunity for systemic reform,” aims for greater centralisation, coordination and consistent service delivery for all New Zealanders. The Government's key changes (announced in April) include disestablishing DHBs, and the creation of a new central entity Health NZ, and independent Maori Health Authority. The major driver behind these reforms is to deliver greater consistency of care across the country and to reduce health inequity among Maori, Pacific and rural populations. We are supportive of the reforms and are engaged with the Transition Unit to keep updated on developments. The new health organisations are set to be in place by July 2022.
  • End of Life Care Act will implement a legally assisted dying service by 7 November 2021. The NZSA is involved in a committee which provides regulatory oversight of the changes. We have been keeping members informed of their obligations under the Act and sharing resources.
  • Climate Change and sustainable healthcare, we support lowering NZ’s carbon footprint to meet our obligations of the Paris Climate Accord and advocate on how the health sector is integral in lowering emissions to reach the Government’s 2030 zero carbon neutral goals. We have advocated that climate change mitigation and adaptation needs to be undertaken within the context of health, wellbeing and equity.  Our Environmental and Sustainability Network drives our work on sustainable healthcare and climate change advocacy.
  • PHARMAC medical devices procurement, is focused on fairer access and equity. We have strongly conveyed that anaesthetists must be represented across multiple committees to advise on medical devices, to reflect the breadth of our specialty’s involvement in the health sector. PHARMAC have been receptive to this advice and we are now awaiting more operational detail on this project. 
  • PHARMAC consultation on its advisory committees aims to make these committees more consumer focused, and able to deliver more equitable outcomes for medicines. 
  • Assistants to the Anaesthetists, we are part of a stakeholder group which aims to bridge AA shortages and ensure a smooth transition to AUT's degree program from the current diploma. A key aim is to ensure the new degree adheres to ANZCA's Position Statement on Assistants to the Anaesthetist to maintain high quality standards of care.

We have most recently developed submissions on funding of assisted dying services for implementation of the End of Life Care Act 2019 and proposals to widen the number of drugs able to be prescribed by designated pharmacist prescribers.

NZSA Submissions


Ministry of Health - Amendments to Designated Pharmacist Prescribers Regulations 2013 and Schedule 1B of the Misuse of Drugs Regulations - 9 August

Ministry of Health - Funding of assisted dying services - 26 July (MOH consultation document here)

PHARMAC - Review of PHARMAC model including questionnaire - 19 July

Medical Council of New Zealand - A doctor’s duty to help in a medical emergency - 9 April

Climate Change Commission - Climate Change Commission report - 28 March 2021

PHARMAC - Consultation on advisory committees - 19 March 2021

PM, Ministers of Health and Climate Change - Health sector contribution to Government's carbon neutral goals - 19 January 2021